Skip to main content
. Author manuscript; available in PMC: 2009 Jun 24.
Published in final edited form as: Vaccine. 2008 May 7;26(27-28):3404–3409. doi: 10.1016/j.vaccine.2008.04.042

Table 1.

Adverse events

Number Severity Relationship to CDA1 Description (number of subjects)
1 Serious Unrelated Alcohol and drug overdose requiring hospitalization, recovered fully (1)
3 Moderate Possibly

  • Transient drop in systolic blood pressure during 8-hour post-infusion period; no treatment required (2)

  • Diarrhea lasting 24 hours, required loperamide (1)
18 Mild Possibly

  • headache (2)

  • nasal congestion (1)

  • abdominal discomfort (1)

  • nausea, loose stools (1)

  • transient blood pressure changes (13)
27 Mild to Moderate Unlikely or Uunrelated

  • headache (4)

  • low grade oral temperature while subject was eating hot soup (1)

  • respiratory symptoms (8)

  • flu-like symptoms (2)

  • viral syndrome (1)

  • transient focal erythema at intravenous catheter site (2)

  • rash over left hip that resolved after topical corticosteroids (1)

  • transient bilateral axillary erythema, no treatment required (1)

  • intermittent abdominal cramps (1)

  • urinary tract infection (1)

  • intermittent knee pain, subsided with analgesics (1)

  • intermittent finger pain (1)

  • transient postural symptoms (1)

  • alcohol intoxication requiring medical treatment, fully recovered (1)

  • excision of digital tumor that was known to exist prior to study enrollment (1)